As IL-6 serum levels are subject to significant inter- and intra-individual variations, SNPs in the IL-6 promoter region have recently been studied in relationship to breast cancer progression and survival due to the known influence of promoter region mutations on expression levels of pro-inflammatory cytokines. The gene discussed is IL6; the disease is breast carcinoma.